Our Insights Oncology Anthony Iannacci 11/3/26 Oncology Anthony Iannacci 11/3/26 Pfizer’s Xtandi + Talzenna Combo Approved in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC), Scoring a Much Broader Label Than J&J’s Akeega Read More Want to get in touch? Click here
Oncology Anthony Iannacci 11/3/26 Oncology Anthony Iannacci 11/3/26 Pfizer’s Xtandi + Talzenna Combo Approved in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC), Scoring a Much Broader Label Than J&J’s Akeega Read More
